Host: Rabbit
Target Protein: ITM2A
IR: Immunogen Range:21-120/263
Clonality: Polyclonal
Isotype: IgG
Entrez Gene: 9452
Swiss Prot: O43736
Source: KLH conjugated synthetic peptide derived from human ITM2A:21-120/263
Purification: affinity purified by Protein A
Storage: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
Background: The type II integral membrane (ITM2) protein family consists of three members ITM2A (also designated E25), ITM2B and ITM2C. ITM2A expression is high in osteogenic and lymphoid tissues, while both ITM2B and ITM2C are expressed in brain. Mutations in the ITM2B gene can lead to familial British dementia (fbd), and autosomal dominant disease characterized by progressive dementia, spasticity, and cerebellar ataxia, or familial Danish dementia (fdd), an autosomal dominant disorder characterized by cataracts, deafness, progressive ataxia, and dementia. The ITM2A 263-amino acid protein contains an N-terminal cytosolic domain, an uncleaved signal anchor sequence, and a tyrosine-rich C-terminal domain. Human ITM2A shares 91% homology with mouse ITM2A.
Size: 200ul
Concentration: 1mg/ml
Applications: WB=1:500-2000, Flow-Cyt=1μg/Test, ELISA=1:5000-10000
Cross Reactive Species: Human (predicted: Mouse,Rat,Pig,Rabbit)
For research use only. Not intended for diagnostic or therapeutic use.